Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adaptimmune Ther ADR (NQ: ADAP )

4.980 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,010
Open 4.980
Bid (Size) 4.950 (9)
Ask (Size) 5.110 (1)
Prev. Close 4.980
Today's Range 4.980 - 4.980
52wk Range 3.380 - 7.340
Shares Outstanding 936,530,694
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Adaptimmune Announces Clinical Responses across Five Solid Tumor Indications with an Overall Response Rate of 36% and Promising Early Durability from its Next-Generation SURPASS Trial
From GlobeNewswire News Releases
Analysts Forecast 34% Gains Ahead For The Holdings of MOON
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel

Performance

YTD
-17.14%
-17.14%
1 Month
-14.43%
-14.43%
3 Month
+41.88%
+41.88%
6 Month
-11.55%
-11.55%
1 Year
+2.26%
+2.26%

More News

Read More
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
From GlobeNewswire News Releases
Adaptimmune Updates Data from its Phase 1 Trial for Liver Cancer at ILCA Showing Clinical Benefit
From GlobeNewswire News Releases
Interesting ADAP Put And Call Options For June 2022
Tags Stocks
From Market News Video
Sum Up The Pieces: MOON Could Be Worth $46
Tags ETFs
From ETF Channel
First Week of November 19th Options Trading For Adaptimmune Therapeutics (ADAP)
Tags Stocks
From Market News Video
Looking Into Adaptimmune Therapeutics's Return On Capital Employed
Tags Market News ADAP BZI/ROCE
From Benzinga
Adaptimmune Shares Encouraging Data From Solid Tumor Trial
Tags Solid Tumor Small Cap Briefs
From Benzinga
3 Biotech Stocks That Could Make You Filthy Rich
Tags ADAP MRNA VSTM
From Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tags MDXG ITMR BZI/TFM
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.